MSH2 and ovarian cancer: In contrast, our patient’s germline variant in MSH2 has been previously characterized as a benign variant, reported in individuals with colorectal, prostate, and ovarian cancers but not meeting clinical criteria for Lynch or Turcot syndrome or showing strong evidence for causality48,49.